Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Inbal

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Israel Journal of Medical Sciences|July 1, 1995
Acquired abnormalities of coagulation: facts to consider in patients with unexpected bleedingA Inbal
The Israel Medical Association Journal : IMAJ|March 25, 2000
S-nitrosoderivative of a recombinant fragment of von Willebrand factor (S-nitroso-Ar545c): a unique antithrombotic agentA Inbal
Harefuah|April 15, 1991
[von Willebrand factor and von Willebrand's disease]A Inbal
Israel Journal of Medical Sciences|September 1, 1990
Acquired von Willebrand's disease, plasma cell dyscrasia, and angiodysplasia: more than a coincidence?A Inbal
Harefuah|June 15, 1993
[Gene therapy: science fiction or reality?]D Blickstein, A Inbal
Harefuah|August 1, 1993
[Desmopressing (DDAVP) treatment in patients with bleeding tendency]O Bairey, A Inbal
Thrombosis Research|November 1, 1989
Glycocalicin binding to von Willebrand factor adsorbed onto collagen-coated or polystyrene surfacesA Inbal, J Loscalzo
Nucleic Acids Research|August 25, 1990
StuI polymorphisms in the vWF geneA Inbal, R I Handin
Nucleic Acids Research|December 11, 1989
Two TaqI polymorphisms in the 5' region of the von Willebrand factor (vWF) geneA Inbal, R I Handin
Harefuah|December 16, 1984
[Auto-erythrocyte sensitization]A Inbal, H Joshua, M Shaklai
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Israel Journal of Medical Sciences|July 1, 1995
Acquired abnormalities of coagulation: facts to consider in patients with unexpected bleedingA Inbal
The Israel Medical Association Journal : IMAJ|March 25, 2000
S-nitrosoderivative of a recombinant fragment of von Willebrand factor (S-nitroso-Ar545c): a unique antithrombotic agentA Inbal
Harefuah|April 15, 1991
[von Willebrand factor and von Willebrand's disease]A Inbal
Israel Journal of Medical Sciences|September 1, 1990
Acquired von Willebrand's disease, plasma cell dyscrasia, and angiodysplasia: more than a coincidence?A Inbal
Harefuah|June 15, 1993
[Gene therapy: science fiction or reality?]D Blickstein, A Inbal
Harefuah|August 1, 1993
[Desmopressing (DDAVP) treatment in patients with bleeding tendency]O Bairey, A Inbal
Thrombosis Research|November 1, 1989
Glycocalicin binding to von Willebrand factor adsorbed onto collagen-coated or polystyrene surfacesA Inbal, J Loscalzo
Nucleic Acids Research|August 25, 1990
StuI polymorphisms in the vWF geneA Inbal, R I Handin
Nucleic Acids Research|December 11, 1989
Two TaqI polymorphisms in the 5' region of the von Willebrand factor (vWF) geneA Inbal, R I Handin
Harefuah|December 16, 1984
[Auto-erythrocyte sensitization]A Inbal, H Joshua, M Shaklai
Pageof 7